TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 130 filers reported holding TCR2 THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $119,000 | -93.0% | 43,123 | -88.2% | 0.00% | -100.0% |
| Q4 2021 | $1,700,000 | +171.1% | 364,726 | +395.0% | 0.00% | – |
| Q3 2021 | $627,000 | -32.9% | 73,686 | +29.3% | 0.00% | -100.0% |
| Q2 2021 | $935,000 | -24.7% | 56,990 | +1.4% | 0.00% | 0.0% |
| Q1 2021 | $1,241,000 | -29.6% | 56,200 | -1.3% | 0.00% | 0.0% |
| Q4 2020 | $1,762,000 | +52.3% | 56,952 | +0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,157,000 | +45.9% | 56,947 | +10.3% | 0.00% | 0.0% |
| Q2 2020 | $793,000 | +162.6% | 51,629 | +32.4% | 0.00% | – |
| Q1 2020 | $302,000 | -35.5% | 39,006 | +19.1% | 0.00% | – |
| Q4 2019 | $468,000 | -4.9% | 32,745 | +0.1% | 0.00% | – |
| Q3 2019 | $492,000 | -1.8% | 32,720 | -6.6% | 0.00% | – |
| Q2 2019 | $501,000 | +1.2% | 35,044 | +23.5% | 0.00% | – |
| Q1 2019 | $495,000 | – | 28,372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $4,046,814 | 1.69% |
| MPM BioImpact LLC | 3,370,982 | $3,367,611 | 0.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,738,947 | $2,735,660 | 0.40% |
| Newtyn Management, LLC | 1,075,000 | $1,073,710 | 0.22% |
| HARBOR CAPITAL ADVISORS, INC. | 68,230 | $68,148 | 0.07% |
| Artal Group S.A. | 750,000 | $749 | 0.04% |
| Oasis Management Co Ltd. | 200,000 | $199,760 | 0.04% |
| Redmile Group, LLC | 731,379 | $730,501 | 0.03% |
| X-Square Capital, LLC | 31,919 | $32 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 68,035 | $67,953 | 0.01% |